Cite
HARVARD Citation
Vital, E. et al. (2014). A1.34 ACPA fine specificity is associated with increased plasmablast numbers and worse clinical response to rituximab in rheumatoid arthritis. Annals of the rheumatic diseases. pp. A14-A15. [Online].